Anil V Vachani from 506 Narberth Ave, Merion Station, PA 19066, age 56, Phone: 6106672727

Name / Title

Company / Classification

Phones & Addresses

Anil Vachani
Pulmonary Critical Care Med , Pulmonary Diseases

Penn. Lung Ctr
Medical Doctor's Office · Nonclassifiable Establishments · Offices of Physicians, Except Mental Health

51 N 39 St, Philadelphia, PA 19104
2156628766

Anil Vachani

Anil Vachani MD
Pulmonologist · Internist

3900 Woodland Ave, Philadelphia, PA 19104
8009491001

Medicine Doctors

Dr. Anil Vachani, Philadelphia PA - MD (Doctor of Medicine)

view source

Specialties:

Critical Care Medicine
Pulmonology

Address:

University Pennsylvania Lung
3400 Civic Center Blvd, Philadelphia, PA 19104
2156623202 (Phone)

Certifications:

Critical Care Medicine, 2004
Internal Medicine, 1999
Pulmonary Disease, 2003

Awards:

Healthgrades Honor Roll

Languages:

English

Hospitals:

University Pennsylvania Lung
3400 Civic Center Blvd, Philadelphia, PA 19104

Presbyterian Hospital
1100 Central Avenue South East, Albuquerque, NM 87106

Hospital of the University of Pennsylvania
3400 Spruce Street, Philadelphia, PA 19104

Education:

Medical School
University Of California, San Francisco, School Of Medicine
Graduated: 1996
Medical School
University Pa
Graduated: 1997
Medical School
University Pa
Graduated: 1999

Anil Vachani, Philadelphia PA

view source

Specialties:

Internal Medicine
Critical Care Medicine
Pulmonary Disease
Critical Care Medicine

Work:

Philadelphia Veterans Affairs Medical Center
3900 Woodland Ave, Philadelphia, PA 19104
Penn. Lung Center
3400 Civic Center Blvd, Philadelphia, PA 19104

Education:

University of California at San Francisco (1996)

License Records

Anil Vachani

Address:

Merion Station, PA 19066

License #:

MD066508L - Active

Category:

Medicine

Type:

Medical Physician and Surgeon

Us Patents

Method For Diagnosing Lung Cancers Using Gene Expression Profiles In Peripheral Blood Mononuclear Cells
view source
US Patent:

8476420, Jul 2, 2013
Filed:

Dec 5, 2008
Appl. No.:

12/745991
Inventors:

Michael Showe - Media PA, US
Louise Showe - Media PA, US
Malik Yousef - Dabburiya Village, IL
Steven M. Albelda - Bala Cynwyd PA, US
Anil Vachani - Merion Station PA, US
Andrei V. Kossenkov - Huntingdon Valley PA, US
Assignee:

The Wistar Institute of Anatomy and Biology - Philadelphia PA
The Trustees of the University of Pennsylvania - Philadelphia PA
International Classification:

C12N 15/11
C12N 15/113
C12N 15/12
C07H 21/04
C12Q 1/68
US Classification:

536 243, 536 231, 536 232, 536 235, 435 614
Abstract:

Methods and compositions are provided for diagnosing lung cancer in a mammalian subject by use of three or more selected genes, e. g. , a gene expression profile, from the peripheral blood mononuclear cells (PBMC) of the subject which is characteristic of disease, a stage of the disease, or enables prognosis of recurrence of disease. The gene expression profile includes three or more genes of Table I, Table II, Table III, Table IV, Table V, Table VI or Table VII herein. Detection of changes in expression in the selected genes forming the gene expression profile from that of a reference gene expression profile are correlated with non-small cell lung cancer (NSCLC). One composition for use in such diagnosis includes three or more PCR primer-probe sets, wherein each primer-probe set amplifies a different polynucleotide sequence from the gene expression profile. Another composition for similar use contains a plurality of polynucleotides immobilized on a substrate, which probes hybridize to three or more gene expression products from genes in the gene expression profile. Still another composition involves detection of the protein expression products of genes from the gene expression profile.

Method For Distinguishing Between Head And Neck Squamous Cell Carcinoma And Lung Squamous Cell Carcinoma
view source
US Patent:

20070264644, Nov 15, 2007
Filed:

Nov 16, 2006
Appl. No.:

11/560410
Inventors:

Louise Showe - Media PA, US
Anil Vachani - Merion Station PA, US
Steven Albelda - Bala Cynwyd PA, US
International Classification:

C12Q 1/68
US Classification:

435006000
Abstract:

The present invention is a method distinguishing between head and neck squamous cell carcinoma and lung squamous cell carcinoma. In particular, a 10-gene classifier has been identified which can be used to distinguish between primary squamous cell carcinoma of the lung and metastatic head and neck squamous cell carcinoma. These genes include CXCL13, COL6A2, SFTPB, KRT14, TSPYL5, TMP3, KLK10, MMP1, GAS1, and MYH2. A panel of one or more of these genes, or proteins encoded thereby, can be used for early diagnosis and selection of an appropriate therapeutic treatment.

Method For Diagnosing Lung Cancers Using Gene Expression Profiles In Peripheral Blood Mononuclear Cells
view source
US Patent:

20140005065, Jan 2, 2014
Filed:

Jun 11, 2013
Appl. No.:

13/914902
Inventors:

Malik Yousef - Dabburiya Village, IL
Steven M. Albelda - Bala Cynwyd PA, US
Anil Vachani - Merion Station PA, US
Andrei V. Kossenkov - Huntingdon Valley PA, US
International Classification:

C12Q 1/68
US Classification:

506 9, 506 16, 506 18
Abstract:

Methods and compositions are provided for diagnosing lung cancer in a mammalian subject by use of three or more selected gene, e.g., a gene expression profile, from the peripheral blood mononuclear cells (PBMC) of the subject which is characteristic of disease, a stage of the disease, or enables prognosis of recurrence of disease. The gene expression profile includes three or more genes of Table I, Table II, Table III, Table IV, Table V, Table VI or Table VII herein. Detection of changes in expression in the selected genes forming the gene expression profile from that of a reference gene expression profile are correlated with non-small cell lung cancer (NSCLC). One composition for use in such diagnosis includes three or more PCR primer-probe sets, wherein each primer-probe set amplifies a different polynucleotide sequence from the gene expression profile. Another composition for similar use contains a plurality of polynucleotides immobilized on a substrate, which probes hybridize to three or more gene expression products from genes in the gene expression profile. Still another composition involves detection of the protein expression products of genes from the gene expression profile.

Method For Diagnosing Lung Cancers Using Gene Expression Profiles In Peripheral Blood Mononuclear Cells
view source
US Patent:

20200191791, Jun 18, 2020
Filed:

Nov 12, 2019
Appl. No.:

16/681046
Inventors:

- Philadelphia PA, US
Malik Yousef - Dabburiya Village, IL
Steven M. Albelda - Bala Cynwyd PA, US
Anil Vachani - Merion Station PA, US
Andrei V. Kossenkov - Huntingdon Valley PA, US
International Classification:

G01N 33/574
C12Q 1/6886
Abstract:

Methods and compositions are provided for diagnosing lung cancer in a mammalian subject by use of three or more selected gene, e.g., a gene expression profile, from the peripheral blood mononuclear cells (PBMC) of the subject which is characteristic of disease, a stage of the disease, or enables prognosis of recurrence of disease. The gene expression profile includes three or more genes of Table I, Table II, Table III, Table IV, Table V, Table VI or Table VII herein. Detection of changes in expression in the selected genes forming the gene expression profile from that of a reference gene expression profile are correlated with non-small cell lung cancer (NSCLC). One composition for use in such diagnosis includes three or more PCR primer-probe sets, wherein each primer-probe set amplifies a different polynucleotide sequence from the gene expression profile. Another composition for similar use contains a plurality of polynucleotides immobilized on a substrate, which probes hybridize to three or more gene expression products from genes in the gene expression profile. Still another composition involves detection of the protein expression products of genes from the gene expression profile.

Method For Diagnosing Lung Cancers Using Gene Expression Profiles In Peripheral Blood Mononuclear Cells
view source
US Patent:

20160282348, Sep 29, 2016
Filed:

Apr 2, 2016
Appl. No.:

15/089485
Inventors:

- Philadelphia PA, US
Malik Yousef - Dabburiya Village, IL
Steven M. Albelda - Bala Cynwyd PA, US
Anil Vachani - Merion Station PA, US
Andrei V. Kossenkov - Huntingdon Valley PA, US
International Classification:

G01N 33/574
C12Q 1/68
Abstract:

Methods and compositions are provided for diagnosing lung cancer in a mammalian subject by use of three or more selected gene, e.g., a gene expression profile, from the peripheral blood mononuclear cells (PBMC) of the subject which is characteristic of disease, a stage of the disease, or enables prognosis of recurrence of disease. The gene expression profile includes three or more genes of Table I, Table II, Table III, Table IV, Table V, Table VI or Table VII herein. Detection of changes in expression in the selected genes forming the gene expression profile from that of a reference gene expression profile are correlated with non-small cell lung cancer (NSCLC). One composition for use in such diagnosis includes three or more PCR primer-probe sets, wherein each primer-probe set amplifies a different polynucleotide sequence from the gene expression profile. Another composition for similar use contains a plurality of polynucleotides immobilized on a substrate, which probes hybridize to three or more gene expression products from genes in the gene expression profile. Still another composition involves detection of the protein expression products of genes from the gene expression profile.